CASP9 and breast cancer: Finally, proteins isolated from tumors showed down-regulation of XIAP as well as cleavage of caspase-9, caspase-3 and PARP following co-treatment with olaparib and embelin indicating that co-targeting PARP and XIAP can regress BC xenografts in nude mice (Figure 5D).